Nano-X Imaging LTD, a Neve Ilan, Israel-based innovative medical imaging technology company, announced the pricing of its initial public offering of 9,178,744 ordinary shares at a price to the public of US$18 per share.
The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Nanox, are expected to be US$165.2m.
In addition, Nanox has granted the underwriters a 30-day option to purchase up to an additional 1,376,812 ordinary shares at the initial public offering price, less underwriting discounts and commissions. All of the shares are being offered by Nanox.
The shares began trading on the Nasdaq Global Market under the ticker symbol “NNOX” on August 21, 2020. The offering is expected to close on August 25, 2020, subject to customary closing conditions.
Cantor Fitzgerald & Co., Oppenheimer & Co. Inc., Berenberg and CIBC Capital Markets are acting as joint book-runners. National Securities Corporation is acting as co-manager for the offering.
In July, the company announced a $110m equity funding round.